🇺🇸 FDA
Pipeline program

TNX-1300

TNX-CE-CI201

Phase 2 small_molecule terminated

Quick answer

TNX-1300 for Cocaine Intoxication is a Phase 2 program (small_molecule) at Tonix Pharmaceuticals Holding with 1 ClinicalTrials.gov record(s).

Program details

Company
Tonix Pharmaceuticals Holding
Indication
Cocaine Intoxication
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials